Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

joseph_papa

Management shake-up at Valeant as Papa expands senior team

August 9, 2016 Manufacturing and Production, Sales and Marketing Valeant, joseph papa, management, shake up

Joseph Papa continues to remodel the plagued Valeant Pharmaceuticals, as a senior management shake-up has seen several new arrivals and …
News

Apellis Pharmaceuticals appoints Dr Robert Kim as CMO

August 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Apellis, CMO, GSK, Novartis, appointment

Clinical stage complement immunotherapy company Apellis Pharmaceuticals has named its new chief medical officer as Dr Robert Kim. Kim’s primary …
Appointment
humira_abbott_

AbbVie files lawsuit against Amgen over Humira copy

August 8, 2016 Research and Development, Sales and Marketing AbbVie, Amgen, FDA, Humira, rheumatoid arthritis

Abbvie has filed a patent infringement lawsuit against Amgen over the latter firm’s copy of its Humira (adalimumab) rheumatoid arthritis …
News
test_results

The power of PrEP

August 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PrEP, high court, lifestyle drug

Many among the general public may not have heard about PrEP, or pre-exposure prophylaxis, before last week when a high …
Feature
indiaflag

Opdivo and Keytruda set for India launches by end of year

August 8, 2016 Sales and Marketing India, keytruda, launch, opdivo

Indian cancer patients could be set to receive two of the world’s leading oncology drugs, MSD’s Keytruda and Bristol-Myers Squibb’s …
News
4741451457_6344b99835_z_-_copy

‘Game changer’ asthma pill sees significant reduction in severe symptoms

August 8, 2016 Research and Development, Sales and Marketing Fevipiprant, Novartis, asthma, university of Leicester

A study at the University of Leicester has found that Fevipiprant (QAW039), the first new asthma pill for nearly 20 …
News
merck_and_co

MSD files Lantus biosimilar with FDA

August 8, 2016 Sales and Marketing FDA, Lantus, MK-1293, MSD, application, biosimilar

MSD, known as Merck in the US and Canada, has filed a new drug application with the US Food and …
News
opdivo_1

Shock for BMS as Opdivo misses goal in late-stage lung cancer trial

August 5, 2016 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Checkmate, lung cancer, opdivo

Bristol-Myers Squibb has announced that its much heralded cancer therapy, Opdivo (nivolumab), failed to meet its primary endpoint of progression-free …
News
novartis_iobmr

NICE recommends Cosentyx in ankylosing spondylitis

August 4, 2016 Research and Development, Sales and Marketing Cosentyx, NICE, Novartis, ankylosing spondylitis

Novartis has announced that the National Institute for Health and Care Excellence (NICE) has recommended Cosentyx (secukinumab) to treat adults …
News
mr058666-web

Merck Q2 results beat analyst estimates

August 4, 2016 Medical Communications, Sales and Marketing Merck, financial results

Germany pharmaceutical firm Merck has announced its fiscal results for Q2 2016, beating analyst estimates with earnings before interest, taxes, …
News
fda2outsideweb

FDA determines Xiamen Origin Biotech wilfully lied to inspectors and customers

August 4, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Xiamen Origin Biotech

The US Food and Drug Administration (FDA) carried out an inspection of Chinese drug manufacturer  Xiamen Origin Biotech, finding the …
News

American pharmacy adds 35 products to list of excluded drugs

August 4, 2016 Sales and Marketing Drug pricing, cvs health, excluded drugs, hyperinflationary

American pharmacy chain CVS Health has added 35 products to its list of excluded drugs and will not cover certain …
News
biogen_austria_238

Takeover rumours send Biogen’s stock soaring

August 3, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Biogen, MSD, rumours, takeover

Rumours have begun to circulate that companies including MSD and Allergan are plotting a takeover bid for Biogen, after a …
News
celgene_1_02

Celgene’s Otezla approved for NHS use

August 3, 2016 Research and Development, Sales and Marketing Celgene, NHS, NICE, apremilast

NICE has published draft guidance recommending the use of Celgene’s Otezla (apremilast) for use on the NHS for treatment of …
News
teva_copy

Teva completes $40 billion acquisition of Actavis Generics

August 3, 2016 Research and Development, Sales and Marketing Actavis, Allergan, Teva, acqusition, generics

Teva has announced that it has completed its acquisition of Actavis Generics, a subsidiary of Allergan, in a transaction valued …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026